Pathway Inhibitors

GSK114 View larger

GSK114

AOB36917

CAS: 1301760-19-9

 

Chemical Name: 3-[(6,7-Dimethoxy-4-quinazolinyl)amino]-4-(dimethylamino)-N-methyl-benzenesulfonamide dihydrochloride

More details

Molarity Calculation Cart®

HOW TO ORDER

$37.50

$37.50 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $16.88 Total: $1,687.50
150 $19.50 Total: $975.00
125 $22.88 Total: $571.88
110 $27.00 Total: $270.00
15 $31.88 Total: $159.38

Data sheet

Molecular FormulaC19H25Cl2N5O4S
Molecular Weight490.40
CAS Numbers1301760-19-9
Storage Condition0°C (short term), -20°C (long term), desiccated
SolubilityDMSO
Purity98% by HPLC
SynonymGSK-114; GSK 114; GSK114.
IUPAC/Chemical Name3-((6,7-dimethoxyquinazolin-4-yl)amino)-4-(dimethylamino)-N-methylbenzenesulfonamide
InChl KeyYUSROMRPOFFTMX-UHFFFAOYSA-N
InChl CodeInChI=1S/C19H23N5O4S/c1-20-29(25,26)12-6-7-16(24(2)3)15(8-12)23-19-13-9-17(27-4)18(28-5)10-14(13)21-11-22-19/h6-11,20H,1-5H3,(H,21,22,23)
SMILES CodeO=S(C1=CC=C(N(C)C)C(NC2=C3C=C(OC)C(OC)=CC3=NC=N2)=C1)(NC)=O
ReferencesBrian G. Lawhorn, Joanne Philp, Alan P. Graves, Lisa Shewchuk, Dennis A. Holt, Gregory J. Gatto Jr., Lara S. Kallander. GSK114: A selective inhibitor for elucidating the biological role of TNNI3K In Press, Accepted Manuscript. 14 May 2016

More info

Novel selective inhibitor for elucidating the biological role of TNNI3K, displaying significant bias (40-fold) for TNNI3K over B-Raf, exceptional broad-spectrum kinase selectivity, and adequate oral exposure to enable its use in cellular and in vivo studies

Customers who bought this product also bought: